Episode 12: SGLT2 Inhibitors - A Cardiac vs Renal Perspective

<p>In this episode, we are joined by Internal Medicine PGY-3s and soon-to-be fellows Dr. Carrie Mahurin and Dr. Jen Bergeron. Together, they review the evidence for or against a broadened therapeutic role of SGLT2 Inhibitors beyond diabetes treatment, in light of new trials suggesting efficacy in heart failure and chronic kidney disease management.</p> <p> </p> <p>Guests: Dr. Carrie Mahurin, MD, PGY3 at UVMMC, and Dr. Jen Bergeron, MD, PGY3 at UVMMC</p> <p> </p> <p>Thumbnail by <a href='https://unsplash.com/@kate_gliz?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText'>Kate Hliznitsova</a> on <a href='https://unsplash.com/s/photos/health?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText'>Unsplash</a></p>